Acta Med. 2013, 56: 52-56

https://doi.org/10.14712/18059694.2014.24

INVASIVE ASPERGILLOSIS IN INTENSIVE CARE UNIT PATIENTS IN IRAN

Mohammad T. Hedayatia,b, Sadegh Khodavaisyc, Masoud Alialyd, Saeed Mahdavi Omrane, Mohammad R. Habibif

aMazandaran University of Medical Sciences, Sari, Iran: Department of Medical Mycology and Parasitology
bMazandaran University of Medical Sciences, Sari, Iran: Invasive Fungi Research Center
cKurdistan University of Medical Sciences, Sanandaj, Iran: Department of Medical Mycology and Parasitology
dMazandaran University of Medical Sciences, Sari, Iran: Pulmonary and Critical Care Division
eBabol University of Medical Sciences, Babol, Iran: Department of Medical Mycology and Parasitology
fMazandaran University of Medical Sciences, Sari, Iran: Anesthesiologist and Critical Care Division

References

1. Acosta J, Catalan M, del Palacio-Peréz-Medel A, et al. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-β-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 2011; 17(7): 1053–60. <https://doi.org/10.1111/j.1469-0691.2010.03357.x>
2. Badiee P, Alborzi A. Invasive fungal infections in renal transplant recipients. Exp Clin Transplant 2011; 9(6): 355–62.
3. Badiee P, Kordbacheh P, Alborzi A, Zeini F, Mirhendi H, Mahmoody M. Fungal infections in solid organ recipients. Exp Clin Transplant 2005; 3(2): 385–9.
4. Becker MJ, Lugtenburg EJ, Cornelissen JJ, van der Schee C. Galactomannan detection in computerized tomography-based bronchoalveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Brit J Haematol 2003; 121: 448–457. <https://doi.org/10.1046/j.1365-2141.2003.04308.x>
5. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica 2006; 91(7): 986–9.
6. Clancy CJ, Jaber RA, Leather LH, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007; 45: 1759–65. <https://doi.org/10.1128/JCM.00077-07> <PubMed>
7. Combes A, Mokhtari M, Couvelard A, et al. Clinical and autopsy diagnoses in the intensive care unit: a prospective study. Arch Intern Med 2004; 164: 389–92. <https://doi.org/10.1001/archinte.164.4.389>
8. Denning DW, Park S, Lass-Florl C, Fraczek MG, et al. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52(9): 1123–9. <https://doi.org/10.1093/cid/cir179> <PubMed>
9. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008 Jun 15; 46(12): 1813–21. <https://doi.org/10.1086/588660> <PubMed>
10. Dutkiewicz R, Hage CA. Aspergillus infections in the critically ill. Proc Am Thorac Soc 2010; 7(3): 204–9. <https://doi.org/10.1513/pats.200906-050AL>
11. Garbino J, Fluckiger U, Elzi L, Imhof A, Bille J, Zimmerli S. Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals. Clin Microbiol Infect 2011; 17(9): 1366–71. <https://doi.org/10.1111/j.1469-0691.2010.03402.x>
12. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9(3): R191–9. <https://doi.org/10.1186/cc3488> <PubMed>
13. Glöckner A, Karthaus M. Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients. Mycoses 2011; 54(5): 420–33. <https://doi.org/10.1111/j.1439-0507.2010.01885.x>
14. Guinea J, Jensen J, Peláez T, et al. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in nonhematological patients with clinical isolation of Aspergillus spp. Med Mycol 2008; 46: 575–579. <https://doi.org/10.1080/13693780801978968>
15. Guinea J, Torres-Narbona M, Gijón P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010; 16(7): 870–7. <https://doi.org/10.1111/j.1469-0691.2009.03015.x>
16. Hedayati MT, Mayahi S, Denning DW. A study on Aspergillus species in houses of asthmatic patients from Sari city, Iran and a brief review of the health effects of exposure to indoor Aspergillus. Environ Monit Assess 2010; 168: 481–487. <https://doi.org/10.1007/s10661-009-1128-x>
17. Hedayati MT, Mayahi S, Movahedi M, Shokohi T. A Study on Fungal Flora of Tap Water as a Potential Reservoir of Fungi in Hospitals from Sari city, Iran. J Mycol Méd 2011; 21: 10–14. <https://doi.org/10.1016/j.mycmed.2010.12.001>
18. Hedayati MT, Mohammadpour RA. A survey on the mycological contamination of the air and the equipment of operating rooms of 17 hospitals. J Med faculty Gilan Univ Med Sci 1999; 8(19): 56–61.
19. Hedayati MT, Mohseni-Bandpi A, Moradi S. A survey on the pathogenic fungi in soil samples of potted plants from Sari hospitals, Iran. J Hosp Infect 2004; 58: 59–62. <https://doi.org/10.1016/j.jhin.2004.04.011>
20. Husain S, Clancy CJ, Nguyen MH, et al. Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin Vaccine Immunol 2008; 15: 1760–3. <https://doi.org/10.1128/CVI.00226-08> <PubMed>
21. Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J, Soubani AO. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 2006 Dec; 21(4): 322–7. <https://doi.org/10.1016/j.jcrc.2006.03.006>
22. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011; 20(121): 156–74. <https://doi.org/10.1183/09059180.00001011> <PubMed>
23. Maertens J, MaertensV, Theunissen K, et al. Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases. Clin Infect Dis 2009; 49: 1688–93. <https://doi.org/10.1086/647935>
24. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45(2): 205–16. <https://doi.org/10.1086/518852>
25. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621–625. <https://doi.org/10.1164/rccm.200401-093OC>
26. Mikulska M, Raiola AM, Bruno B, et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44(6): 361–70. <https://doi.org/10.1038/bmt.2009.39>
27. Morace G, Borghi E. Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol 2010; 76(11): 950–6.
28. Mort TC, Yeston NS. The relationship of pre mortem diagnoses and post mortem findings in a surgical intensive care unit. Crit Care Med 1999; 27: 299–303. <https://doi.org/10.1097/00003246-199902000-00035>
29. Pasqualotto AC, Xavier MO, Sánchez LB, et al. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation. 2010; 90(3): 306–11. <https://doi.org/10.1097/TP.0b013e3181e49bc1>
30. Patel DA, Gao X, Stephens JM, Forshag MS, Tarallo M. US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host. J Med Econ 2011; 14(2): 227–37. <https://doi.org/10.3111/13696998.2011.564246>
31. Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56 Suppl 1: i5–i11. <https://doi.org/10.1093/jac/dki218>
32. Sanguinetti M, Posteraro B, Pagano L, et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme- linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2003; 41: 3922–5. <https://doi.org/10.1128/JCM.41.8.3922-3925.2003> <PubMed>
33. Shoham S, Marwaha S. Invasive fungal infections in the ICU. J Intensive Care Med 2010; 25(2): 78–92. <https://doi.org/10.1177/0885066609355262>
34. Silfvast T, Takkunen O, Kolho E, Andersson L, Rosenberg P. Characteristics of discrepancies between clinical and autopsy diagnoses in the intensive care unit: a 5-year review. Intensive Care Med 2003; 29: 321–4. <https://doi.org/10.1007/s00134-002-1576-z>
35. Smith JA, Kauffman CA. Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit. Crit Care Med 2010; 38(8 Suppl): S380–7. <https://doi.org/10.1097/CCM.0b013e3181e6cf25>
36. Thornton CR. Detection of invasive aspergillosis. Adv Appl Microbiol 2010; 70: 187–216. <https://doi.org/10.1016/S0065-2164(10)70006-X>
37. Tortorano AM, Dho G, Prigitano A, et al. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006–2008). Mycoses 2012; 55(1): 73–79. <https://doi.org/10.1111/j.1439-0507.2011.02044.x>
38. Zilberberg MD, Shorr AF. Fungal infections in the ICU. Infect Dis Clin North Am 2009; 23(3): 625–42. <https://doi.org/10.1016/j.idc.2009.04.008>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive